rs120074125
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000342245.9(SMPD1):āc.1177T>Gā(p.Trp393Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W393R) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000342245.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMPD1 | NM_000543.5 | c.1177T>G | p.Trp393Gly | missense_variant | 3/6 | ENST00000342245.9 | NP_000534.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMPD1 | ENST00000342245.9 | c.1177T>G | p.Trp393Gly | missense_variant | 3/6 | 1 | NM_000543.5 | ENSP00000340409 | P3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249362Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135270
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461692Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727132
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Niemann-Pick disease, type A Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 17, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 24, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Aug 17, 2016 | - - |
Niemann-pick disease, intermediate, protracted neurovisceral Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 1995 | - - |
Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 13, 2023 | This sequence change replaces tryptophan, which is neutral and slightly polar, with glycine, which is neutral and non-polar, at codon 393 of the SMPD1 protein (p.Trp393Gly). This variant is present in population databases (rs120074125, gnomAD 0.0009%). This missense change has been observed in individuals with Niemann-Pick disease (PMID: 7762557, 17360762). It has also been observed to segregate with disease in related individuals. This variant is also known as W391G. ClinVar contains an entry for this variant (Variation ID: 2991). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SMPD1 function (PMID: 7762557). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | SMPD1: PP1:Strong, PM2, PM3, PM5, PP4:Moderate, PS3:Moderate, PP3 - |
Sphingomyelin/cholesterol lipidosis Pathogenic:1
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 22, 2020 | The p.Trp393Gly variant in SMPD1 (also known as p.Trp391Gly due to a difference in cDNA numbering) has been reported in at least 25 individuals with Niemann-Pick disease, segregated with disease in 11 affected relatives from 3 families (PMID: 7762557, 17360762), and has been identified in 0.0002% (1/113046) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs120074125). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (VariationID: 2991) as pathogenic by Counsyl and OMIM. In vitro functional studies provide some evidence that the p.Trp393Gly variant may impact protein function (PMID: 7762557). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in at least 25 affected homozygotes increases the likelihood that the p.Trp393Gly variant is pathogenic (PMID: 7762557, 17360762). The phenotype of individuals homozygous for this variant is highly specific for Niemann-Pick disease based on acid sphingomyelinase activity being <10% of normal, consistent with disease (PMID: 7762557). In summary, this variant meets criteria to be classified as pathogenic for Niemann-Pick disease in an autosomal recessive manner based on its presence in related and unrelated affected homozygotes, functional studies, and the phenotype of individuals with the variant being highly specific for disease. ACMG/AMP Criteria applied: PP1_strong, PS3, PM2, PM3, PP3, PP4 (Richards 2015). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at